December 2, 2013 – Claret Medical Submits an Investigational Device Exemption (IDE) for the Sentinel™ Cerebral Protection System. The SENTINEL Pivotal Study Will Evaluate the Cerebral Protection Device in the Transcatheter Aortic Valve Replacement (TAVR) Population.
February 27, 2013 – Claret Medical Announces the Recent CE Mark Approval of its Next Generation Embolic Protection System, the Montage 2™ Dual Filter System, to Reduce Stroke During Transcatheter Aortic Valve Replacement (TAVR).
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. Click here for the Indication, Contraindications, Warnings, and Precautions.